Satsuma Pharmaceuticals
0
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Dividends
0%Dividend Yield
Apr 2014
€0.14
Feb 2014
€0.15
Nov 2013
€0.15
Aug 2013
€0.15
Jul 2013
€0.27
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Show More
CEO
John Kollins
Employees
25
Country
United States
ISIN
US80405P1075
WKN
000A2PQPD
Listings
0 Comments
Share your thoughts
FAQs
What is Satsuma Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Satsuma Pharmaceuticals stocks are traded under the ticker 1LV.MU.
Does Satsuma Pharmaceuticals pay dividends?▼
Yes, 1LV.MU dividends are paid quarterly. The last dividend per share was 0.14 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Satsuma Pharmaceuticals have?▼
As of November 3, 2026, the company has 25 employees.
In which sector is Satsuma Pharmaceuticals located?▼
Satsuma Pharmaceuticals operates in the Manufacturing sector.
When did Satsuma Pharmaceuticals complete a stock split?▼
Satsuma Pharmaceuticals has not had any recent stock splits.
Where is Satsuma Pharmaceuticals headquartered?▼
Satsuma Pharmaceuticals is headquartered in South San Francisco, United States.